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Abstract
An 84-year-old woman was examined for an enlargement of an induration in the left breast. A ventriculoperitoneal
shunt had been placed for postoperative normal pressure hydrocephalus of a cerebral hemorrhage, and it had
penetrated the mass according to the computed tomography findings. Breast cancer was diagnosed after a close
examination; however, close observation was selected because her family rejected treatment. She developed
somnolence 7 months after the initial examination, and ventricular dilatation and expansion of the low-density
region around the ventricle were noted on computed tomography, suggesting that the enlarged tumor had
excluded the shunt and caused obstruction. The growth of breast carcinoma involving a shunt tube can be the
cause of obstruction of a ventriculoperitoneal shunt. Our findings suggest that a breast lesion should be evaluated at
both pre- and postoperation.
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Background
Ventriculoperitoneal (VP) shunt operation is the
common neurosurgical procedure for hydrocephalus.
Although a VP shunt is frequently associated with
complications, the complications related to the breast
are rare according to the previous literature. These
include cerebrospinal fluid (CSF) pseudocysts, CSF
galactorrhea, and the migration of the shunt tube in-
side the silicone breast implant. We herein present a
case of breast cancer involving a VP shunt with a re-
view of the pertinent literature.
Case presentation
The patient was an 84-year-old woman in whom a
VP shunt had been placed for normal pressure
hydrocephalus after a cerebral hemorrhage at 69 years
of age, and she was in a state of dysbasia with an
Eastern Cooperative Oncology Group (ECOG) per-
formance status (PS) of 3. While staying in a facility,
a mass in the left breast had been noted on a visiting
examination by the primary care hospital staff. Since
the mass was enlarged, she was examined by a
physician. A 3-cm hard mass retracting the dark red
skin was palpated on the medial side of the left
breast (Fig. 1). Differentiation of a subcutaneous ma-
lignant tumor was also considered; however, left
breast cancer was suspected according to the ultra-
sonography findings, and fine needle aspiration cy-
tology (FNAC) was performed. The cytological
findings showed increases in the nucleus/cytoplasm
(N/C) ratio and chromatin content, an aggregation of
atypical cells, and intracytoplasmic lumen. According
to these findings, the mass was diagnosed as infiltrat-
ing breast cancer. The carcinoembryonic antigen
(CEA) level was 8.0 ng/ml, cancer antigen15-3
(CA15-3) was 42.2 U/ml, and breast carcinoma-
associated antigen225 (BCA225) was 210 U/ml, all of
which were elevated. On whole-body computed tom-
ography (CT), the mass was observed to involve the
VP shunt (Fig. 2) and infiltrated the mammary gland
over the skin; however, axillary lymph node metastasis
and distant metastasis were not observed. Because
damage to the shunt due to a needle puncture was a
concern, the patient was referred to the neurosurgery
department of our hospital; however, there was no
problem with the shunt. En bloc resection of the VP
shunt and breast was recommended to prevent prob-
lems with the shunt, but close observation was
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selected because her family rejected any treatment. At
7 months after the initial examination, the tumor
marker levels were higher: CEA, 9.5 ng/ml; CA15-3,
56 U/ml; and BCA225, 200 U/ml. Skin redness and
lethargy developed, and tumor enlargement was ob-
served. A CT scan of the head showed dilated ventri-
cles and the enlargement of periventricular lucency,
suggesting that the tumor enlargement caused the ob-
struction (Fig. 3a, b). Three months later, the patient
became bedridden and suffered from aspiration pneu-
monia due to dysphagia.
Discussion
Hydrocephalus can be developed in all generations.
Many hydrocephalus patients receive a CSF shunt,
which is applied to 16,000 patients annually in Japan,
and a VP shunt is most frequently placed. The aver-
age lifespan of Japanese women has exceeded 80 years,
and the elderly population is increasing. Therefore,
the number of shunt operations performed annually is
likely to increase due to an increase in elderly pa-
tients. On the other hand, the incidence of breast
cancer has continuously increased in Japan. The num-
ber of breast cancer patients with CSF shunts may be
increasing. Complications frequently associated with a
VP shunt, including shunt obstruction, infection,
overdrainage of CSF, and perforation of the gastro-
intestinal tract, gallbladder, vagina, and abdominal
wall at the umbilicus, have also been reported [1]. Re-
garding complications associated with the mammary
gland, CSF pseudocysts due to the leakage of CSF
from the catheter shunt obstruction, CSF galactor-
rhea, and shunt migration of the VP shunting catheter
under or within silicone breast implants have been
previously reported; however, they are considered to
be very rare [2–5].
In the present patient, breast cancer involving a VP
shunt was observed, which is very rare and only
three cases have been previously reported in the English
literature [6–8] (Table 1). All patients had advanced
age (67 to 88 years of age). As a person ages, atrophy
of the breast become progressive and fat tissue re-
places the breast tissue. Therefore, a shunt can easily
insert into the breast tissue that has been replaced
with fat tissue in cases of shunt operation. We specu-
late that this is the cause of breast-related shunt
complications. Since a silicone catheter is very soft, it
is unlikely that the shunt catheter pierced the breast
cancer. The cancer may have developed and grew
around and involved the shunt catheter. In the pub-
lished literature, only one case of breast cancer dem-
onstrated neurologic symptoms due to shunt trouble
[6]. This previous case was detected at screening
without symptoms; in another case and our case, a
skin lesion was noted without other neurologic symp-
toms [7, 8]. Therefore, it is important to perform
breast cancer screening before and after the shunt op-
eration. FNAC was performed for the diagnosis of
breast cancer in three cases including our case. In
our case, FNAC was performed before CT screening,
while in the other two cases, it was performed after
CT screening or magnetic resonance imaging (MRI)
scan. Therefore, the positional relationship between
the tumor and shunt tube should be confirmed before
aspiration in cases in which the shunt tube and
tumor are on the same side of the chest.
Roka et al. reported consciousness disturbance due
to hydrocephalus symptoms induced by catheter ob-
struction by a breast cancer mass [6]. Our case was
not treated, and stenosis by catheter compression oc-
curred 7 months after the initial examination. The
ventricle was dilated and periventricular lucency ex-
panded, suggesting the aggravation of hydrocephalus.
However, the PS and consciousness of our patient
Fig. 1 A mass accompanied by redness was present in the medial
region of the left breast
Fig. 2 A CT scan showed that the tumor involved the VP shunt
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was poor from the first visit, thus it was difficult to
determine worsening of her condition, except that she
was somnolent and bedridden. If the breast cancer
was discovered earlier, there might be a possibility
that the shunt tube had not been involved with breast
cancer. Taken together, partial resection of the breast
under local anesthesia may be a treatment of choice
leading to convince her family. Therefore, this out-
come may have been changed.
Regarding breast cancer operation, resection of the
breast cancer, including shunt placement and rerout-
ing of the shunt, is necessary to prevent dissemin-
ation through the catheter by a breast surgeon and
neurosurgeon in close cooperation with one other.
There was no effective means to treat this case, while
her family did not want us to perform any invasive
treatments or diagnostic procedures. However, endo-
crine therapy would have been one treatment option
for this patient. Various diagnostic procedures, includ-
ing US-guided biopsy and incision biopsy should be
performed in such cases to obtain tissue samples and
thereby identify the intrinsic subtype. For cases with
skin involvement, intervention can also be performed
without damaging the shunt tube in order to obtain
subcutaneous tissue that may have become infiltrated
with cancer cells. Even if such tissue sampling proves
to be impossible, treating such patients with endo-
crine therapy is still one therapeutic alternative.
In any case, regular breast cancer screening after shunt
operation is necessary.
Conclusions
We herein encountered a very rare case of breast cancer
involving a VP shunt. In Japan, the incidence of breast
cancer and the number of elderly individuals have in-
creased. An evaluation for breast cancer before shunt
placement, in addition to an examination of the body
surface, and follow-up breast cancer screening after
shunt placement is necessary.
Consent
Written informed consent was obtained from the
patient for publication of this case report and any ac-
companying images. A copy of the written consent is
available for review by the Editor-in-Chief of this
journal.
Fig. 3 Brain CT showed that the ventricle was more dilated and the low-density region around the ventricle had expanded within 7 months (b)
after the initial visit to our hospital (a)
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No symptoms (hard skin
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FNAC No treatment
NPH normal pressure hydrocephalus, FNAC fine needle aspiration cytology
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